☰

Antony S. Tin, Ph.D.

Affiliations: 
2013 Endocrinology University of California, Berkeley, Berkeley, CA, United States 
Area:
Molecular Biology, Cell Biology, Oncology
Google:
"Antony Tin"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Gary L Firestone grad student 2013 UC Berkeley
 (Development of a Breast Cancer Stem Cell Model and the Inhibitory Regulation of Small Molecule Phytochemicals on Various Stages of Human Breast Cancer Cells.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tin AS, Park AH, Sundar SN, et al. (2014) Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells. Bmc Biology. 12: 72
Tran KQ, Tin AS, Firestone GL. (2014) Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling. Anti-Cancer Drugs. 25: 270-81
Tin AS, Sundar SN, Tran KQ, et al. (2012) Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes. Anti-Cancer Drugs. 23: 370-9
Marconett CN, Sundar SN, Tseng M, et al. (2011) Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells. Carcinogenesis. 32: 1315-23
Willoughby JA, Sundar SN, Cheung M, et al. (2009) Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression. The Journal of Biological Chemistry. 284: 2203-13
See more...